Immunotherapeutic options for metastatic pancreatic cancer

In this review, Immodulon along with clinical collaborators gives an overview of new immune-related therapeutic strategies currently being tested in clinical trials in metastatic pancreatic cancer. This paper proposes that immunotherapeutic strategies in combination with current therapies may offer new hopes in this most deadly disease.


Full title: Have lessons from past failures brought us closer to the success of immunotherapy in metastatic pancreatic cancer?

Journal: Oncoimmunology
Author[s]: Rosa Brunet L., Hagemann T., Gaya A., Mudan S., Marabelle A.

Date: December 2015

DOI: doi.org/10.1080/2162402X.2015.1112942


Click here to read the full article